Carina Jing Xuan Tay,Clara Wt Koh,Martin Qui et al.
Carina Jing Xuan Tay et al.
Family outcomes of the novel ECHO framework implemented in Singapore's early intervention programme [0.03%]
新加坡新型ECHO框架在早期干预计划中的家庭结局研究
Hong Huay Lim,Audrey De Cruz,Hwee San Low et al.
Hong Huay Lim et al.
Transcatheter aortic valve in transcatheter aortic valve: Clinical characteristics and outcomes [0.03%]
经导管主动脉瓣植入的临床特点和预后
Hai Yang Fang,See Hooi Ewe,Mohammed Rizwan Amanullah et al.
Hai Yang Fang et al.
Systemic disconnects in musculoskeletal healthcare across the care continuum [0.03%]
肌骨卫生保健连续性中的系统脱节现象
Arun-Kumar Kaliya-Perumal,Oliver Roberts,Bryan Yijia Tan
Arun-Kumar Kaliya-Perumal
Singapore Myeloma Study Group consensus guidelines for the management of patients with newly diagnosed multiple myeloma [0.03%]
新加坡骨髓瘤研究组关于初诊多发性骨髓瘤患者管理的共识指南
Sanjay de Mel,Allison Cy Tso,Cinnie Y Soekojo et al.
Sanjay de Mel et al.
In my time: A qualitative exploration of the junior doctor experience in Singapore over the years [0.03%]
我的时光：多年来新加坡实习医生经历的定性探索
Caitlin Alsandria O&#x;Hara,Nur Haidah Ahmad Kamal,En Ci Isaac Ong et al.
Caitlin Alsandria O&#x;Hara et al.
Introduction: Despite efforts to improve junior doctors' working conditions, burnout, distress and disillusionment persist, with implications for patient outcomes. This qualitative study analysed factors shaping the lived...
Childhood-onset Takayasu arteritis: Unique characteristics and outcomes from a Singapore cohort [0.03%]
儿童期起病的塔克扎斯动脉炎：来自新加坡队列的独特特征和结果
Amanda Xin Yi Yap,Junjie Huang,Kai Liang Teh et al.
Amanda Xin Yi Yap et al.
Introduction: Takayasu arteritis is the most common large-vessel vasculitis in childhood, but there is a lack of literature regarding childhood-onset Takayasu arteritis (c-TAK) in Southeast Asia. We aim to describe a c-TA...
Surviving the year: Predictors of mortality in conservative kidney management [0.03%]
保守性肾脏治疗中的生存预测因素：一年存活者的回顾性分析
Swee Ping Teh,Boon Cheok Lai,Ivan Wei Zhen Lee et al.
Swee Ping Teh et al.
Introduction: Conservative kidney management (CKM) is a recognised treatment option for selected patients with chronic kidney disease stage 5 (CKD G5), but prognostic indicators for mortality and optimal timing for pallia...